https://drugnews.com.tw/articles/2026-09-28-jnj-orthopaedics-separation-en.html Drugnews｜藥時事 en 2026-09-28T00:00:00.000Z US$9.2 Billion in Annual Sales—Why Does J&J Still Want to Separate Orthopaedics? https://drugnews.com.tw/articles/2026-09-28-jnj-orthopaedics-separation.html Drugnews｜藥時事 zh-tw 2026-09-28T00:00:00.000Z 年營收 92 億美元，強生為什麼還想把骨科拆出去？ https://drugnews.com.tw/articles/2026-09-27-hibsago-finite-hbv-care-en.html Drugnews｜藥時事 en 2026-09-27T00:00:00.000Z New Hepatitis B Drug Approved in Japan: About One in Five Treated Trial Patients Achieved a “Functional Cure” https://drugnews.com.tw/articles/2026-09-27-hibsago-finite-hbv-care.html Drugnews｜藥時事 zh-tw 2026-09-27T00:00:00.000Z B 肝新藥在日本獲准，新藥組約兩成受試者達「功能性治癒」